HC Wainwright maintains NewAmsterdam Pharma price target at $52
HC Wainwright & Co. maintained its price target for NewAmsterdam Pharma at $52.00 per share,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.